BISPECIFIC ANTIBODIES TARGETING CD47 AND PD-L1 AND METHODS OF USE THEREOF

CD123 TARGETED IMMUNOTHERAPIES

COMBINATION THERAPY FOR THE TREATMENT OF SOLID AND HEMATOLOGICAL CANCERS

A NEUROPILIN ANTAGONIST IN COMBINATION WITH A P38ALPHA-KINASE INHIBITOR FOR THE TREATMENT OF CANCER

GRP78-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodies

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

IL1RAP ANTIBODIES

Immunomodulation and anti-tumor-related nanobody and nucleic acid encoding sequence thereof, and uses of the same

MATERIALS AND METHODS FOR MODULATING AN IMMUNE RESPONSE

EX VIVO GAMMA DELTA T CELL POPULATIONS

ANTI-CANCER PEPTIDE

Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody

Antibodies To Cell Adhesion Molecule-Related/Down-Regulated By Oncogenes (CDON) And Uses Thereof

Photosensitizing antibody-fluorophore conjugates

MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF

Compositions and methods to regulate Renalase in the treatment of cancer

Method and Compositions for Inducing Differentiation of Myeloid Derived Suppressor Cell to Treat Cancer and Infectious Diseases

Chimeric antigen receptors against multiple HLA-G isoforms

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Markers of acute myeloid leukemia stem cells

Covalent Diabodies and Uses Thereof

POLYPEPTIDES FOR TREATMENT OF AML

ANTI-MUTATION TYPE FGFR3 ANTIBODY AND USE THEREFOR

ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

NKG2A ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

BINDING MOLECULES FOR BCMA AND CD3

Anti-B7-H4 antibodies and immunoconjugates

BISPECIFIC BINDING PROTEINS AND USES THEREOF

FUSIONS OF MUTANT INTERLEUKIN-2 POLYPEPTIDES WITH ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION

CD137- and DLL3-targeting multispecific antigen-binding molecules

Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody

AGENTS THAT INTERFERE WITH THYMIC STROMAL LYMPHOPOIETIN (TSLP)-RECEPTOR SIGNALING

METHODS AND COMPOSITIONS RELATING TO ANTI-NUCLEOLIN RECOMBINANT IMMUNOAGENTS

FUSION PROTEIN COMPRISING ANTI-MESOTHELIN ANTIBODY, ANTI-CD3 ANTIBODY OR ANTI-EGFR ANTIBODY, BISPECIFIC OR TRISPECIFIC ANTIBODY COMPRISING SAME, AND USES THEREOF

FUSION PROTEIN AND USE THEREOF

ANTIBODIES AGAINST PD-1 AND METHODS OF USE THEREOF

Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor

NTRK FUSION MOLECULES AND USES THEREOF

RECOMBINANT FAP BINDING PROTEINS AND THEIR USE

GHR-106 CHIMERIC ANTIGEN RECEPTOR CONSTRUCT AND METHODS OF MAKING AND USING SAME

THERAPEUTIC B-CELLS ENGINEERED TO EXPRESS BISPECIFIC T CELL ENGAGER ANTIBODIES

IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS

HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF

ANTIBODY WITH ENHANCED BINDING AFFINITY FOR ENDOTHELIN RECEPTOR TYPE A

ANTI-ADAM8 ANTIBODIES AND USES OF THE SAME

MONOCLONAL ANTIBODY AND A METHOD OF USE FOR THE TREATMENT OF LUPUS

ANTI-ROR1 / ANTI-CD3 BISPECIFIC BINDING MOLECULES

Anti-EGFR antibody-drug conjugates

T cell activating bispecific antigen binding molecules

AFFINITY MATURATED TAG72 SPECIFIC SINGLE CHAING ANTIBODIES

ANTI-LAG-3 BINDING MOLECULES

Separation moieties and methods of use thereof

COMBINATION THERAPY

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

T cell activating bispecific antigen binding molecules

Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptor

MÜLLERIAN INHIBITING SUBSTANCE TYPE 2 RECEPTOR (MISIIR)-SPECIFIC CAR T CELLS FOR THE TREATMENT OF OVARIAN CANCER AND OTHER GYNECOLOGIC MALIGNANCIES

BISPECIFIC ANTIBODIES AGAINST CHI3L1 AND PD1 WITH ENHANCED T CELL-MEDIATED CYTOTOXIC EFFECTS ON TUMOR CELLS

ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

ANTIBODIES AGAINST PROGRAMMED CELL DEATH PROTEIN 1 (PD1) AND USES THEREOF

BISPECIFIC ANTIBODIES TO ROR1 AND CD3

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Antibody or chimeric antigen receptor which targets Claudin 18.2

IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS

ANTI-PD-1 ANTIBODIES AND USES THEREOF

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

PATHOGEN BINDING METHODS AND COMPOSITIONS

T CELL RECEPTORS RECOGNIZING HLA-A1-RESTRICTED MAGE-A3

Helicobacter therapeutic

Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 context

ANTI-AXL ANTIBODIES

LAG-3 binding members

Anti-CD100 antibodies and methods for using the same

ANTI FGF23 ANTIBODY

COMBINATION THERAPY FOR CANCER TREATMENT

CARRIER-BINDING AGENT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

Nucleic acids encoding antagonistic CD40 monoclonal antibodies

CLAUDIN-6 BISPECIFIC ANTIBODIES

Chimeric antigen receptors (CARS) that bind osteosarcoma and their use in medicine

ANTI-HER2 BINDING MOLECULES

METHODS OF DEPLETING DISEASE CAUSING AGENTS VIA ANTIBODY TARGETED PHAGOCYTOSIS

BISPECIFIC ANTIBODIES AND USES THEREOF

Heterodimeric antibodies that bind CD3 and tumor antigens

METHODS OF USING MONOCLONAL ANTIBODIES TARGETING EPITOPES OF ASPH

Anti-B7-H4 antibodies and immunoconjugates

Anti-CD112R compositions and methods

Heterodimeric antibodies that bind somatostatin receptor 2

Antibodies having specificity for BTN2 and uses thereof

ANTI-CD79B ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF

FLT3-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USING THE SAME

BISPECIFIC ANTIBODIES FOR USE IN STEM CELL TRANSPLANTATION

ANTI-TROPHOBLAST CELL SURFACE ANTIGEN 2 (TROP2) ANTIBODIES AND ANTIBODY DRUG CONJUGATES COMPRISING SAME

Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)

ANTI-ALPHABETATCR ANTIBODY

Anti-IGFBP-3R antibodies and methods of treating an IGFBP-3R expressing cancer

Chemically-Locked Bispecific Antibodies

Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancer

Humanized anti-VEGF monoclonal antibody

Bispecific HER2 Ligands for Cancer Therapy

CHIMERIC ANTIGEN RECEPTOR COMPRISING INTERLEUKIN-15 INTRACELLULAR DOMAIN AND USES THEREOF

Treatment or prevention method of radiation damage by administration of IL-5 receptor alpha chain binding antibody

Antibodies and variants thereof against PD-L1

Bispecific antibody specifically binding to GPNMB and CD3, and use thereof

TRAILshort antibody and methods of use

Anti-Vβ17/anti-CD123 bispecific antibodies

Compositions and methods for modulating delta gamma chain mediated immunity

UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY

Trispecific and/or trivalent binding proteins

PLECTIN-1 BINDING ANTIBODIES AND USES THEREOF

Method of treating a tumor using anti-TfR antibodies

Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases

ANTI-PD-L1 ANTIBODIES AND USES THEREOF

Anti-B7-H3 antibody

CD3-SPECIFIC BINDING MOLECULES

Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

MODULATION OF DENDRITIC CELL LINEAGES

POLYSACCHARIDE COMPOSITIONS FOR USE IN TREATING FILARIASIS

ANTI-OX40 ANTIBODIES AND THEIR USES

ANTIGEN-BINDING MOLECULE COMPRISING ALTERED ANTIBODY VARIABLE REGION

ANTIBODIES SPECIFIC TO HUMAN NECTIN-2

TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS

Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereof

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS

ANTIBODIES TO M(H)DM2/4 AND THEIR USE IN DIAGNOSING AND TREATING CANCER

GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) ANTIBODIES AND METHODS OF USE THEREOF

ANTI-PD-1 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND PHARMACEUTICAL USE THEREOF

Chimeric engulfment receptor molecules

ANTIBODY-TUMOR NECROSIS FACTOR alpha FUSION PROTEIN AND ITS PREPARATION AND APPLICATIONS

NOVEL CANCER ANTIGENS AND ANTIBODIES OF SAID ANTIGENS

Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

COMPOSITIONS AND METHODS FOR MODULATING CELLULAR INTERNALIZATION

ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF

FCMR-binding molecules and uses thereof

HETERODIMERIC FUSION PROTEIN

Anti-BCMA chimeric antigen receptors

Alpha and gamma-D polyglutamated pemetrexed antifolates and uses thereof

Alpha polyglutamated pemetrexed and uses thereof

Polyglutamated pemetrexed and uses thereof

Combinations and uses thereof

COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

NOVEL AGONISTIC ANTI TNFR2 ANTIBODY MOLECULES

IL-6 binding molecules

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Methods of treating aging-related disorders

Binding molecules for BCMA and CD3

Therapeutic anti-CD9 antibody

Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3

Anti-CTLA-4 Binding Proteins and Methods of Use Thereof

MULTISPECIFIC ANTIGEN BINDING PROTEINS CAPABLE OF BINDING CD19 AND CD3, AND USE THEREOF

Drug regulated transgene expression

Dynamic I/O virtualization system having guest memory management for mapping virtual addresses using virtualization application programming interface (API) in guest kernal

Glycan-Interacting Compounds and Methods of Use

Caninized human antibodies to human IL-4R alpha

BAFF-R BISPECIFIC T-CELL ENGAGER ANTIBODY

Security of dynamic I/O virtualization system having a bidirectional extended hybrid address space (EHAS) for allowing host kernel to access guest memory

Treatment of eosinophil or mast cell related disorders

MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)

ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF

TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE

Humanized and affinity matured antibodies to FcRH5 and methods of use

Anti-IL-6 antibody

csPCNA Isoform Antibodies And Uses Thereof

Heterodimeric antibodies that bind CD3 and tumor antigens

Methods for treating multiple myeloma

Combination Therapy for the Treatment of Cancer

ANTI-FGF19 ANTIBODIES

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Materials and methods for multidirectional biotransportation in virotherapeutics

Multispecific antibodies

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

COMPOUNDS AND METHODS FOR TREATMENT OF HEAD AND NECK CANCER

Markers of acute myeloid leukemia stem cells

Humanized and affinity-matured anti-CEACAM1 antibodies

Human antibodies to human delta like ligand 4

Antibodies and therapeutic uses thereof

Articles and methods directed to personalized therapy of cancer

Bispecific binding molecules binding to VEGF and Ang2

EGFR binding proteins and methods of use

Therapeutic antibodies and their uses

CD47 ANTIBODY, PREPARATION METHOD THEREFOR AND USES THEREOF

CELL-PENETRATING ANTI-DNA ANTIBODIES AND USES THEREOF INHIBIT DNA REPAIR

CLEC12AxCD3 bispecific antibodies and methods for the treatment of disease

Constructs for chimeric antigen receptors

ANTIBODIES TARGETING EPN1

BISPECIFIC ANTIBODY BINDING TO CD20 AND CD3 AND USES THEREOF

Antigen Binding Proteins that Bind c-Met

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

Targeted Immunotolerance

BISPECIFIC ANTIBODY, PREPARATION METHOD THEREOF AND APPLICATION THEREOF

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS

Bispecific antigen-binding constructs targeting HER2

Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating MUC16-positive cancer

Chimeric antigen receptor

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bind PSMA and CD3, and Uses Thereof

Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof

Chimeric antigen receptors against multiple HLA-G isoforms

Method of treating lung cancer

HER-2 binding antibodies

Antigen-binding constructs targeting HER2

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

Bispecific EGFR/c-Met antibodies

Anti-Met fab-Fc for the treatment of a tumor and/or metastasis

Preparation and use of anti-MET-and-RON bispecific antibody and antibody-drug conjugate thereof

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Methods of inhibiting complement factor H (CFH) comprising administering an antibody that binds CFH

GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF

Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS

COMBINE HARVESTER CONCAVE THRESHING BAR

Anti-PD-L1 antibody and use thereof

Methods for achieving therapeutically effective doses of anti-CD47 agents

COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY

Modulators of ROR1-ROR2 binding

Bispecific antibodies for use in the treatment of hematological malignancies

Immunocytes expressing a chimeric antigen receptor binding to cancer cells and TNF-related apoptosis-inducing ligand (trail)

IL2 AND TNF MUTANT IMMUNOCONJUGATES

COMBINATION THERAPY FOR CANCER TREATMENT

PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN

T CELL RECRUITING POLYPEPTIDES BASED ON CD3 REACTIVITY

COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS AND IMMUNO-ONCOLOGY AGENTS

Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

Anti-Vista Antibodies And Fragments, Uses Thereof, And Methods Of Identifying Same

ROR2 antibody compositions and related methods

BLYS ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Compounds and methods for treating pain

ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF

Bacterial biomarker

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

High affinity B7-H6 antibodies and antibody fragments

Gene Signatures for Determining ICOS Expression

MULTI-SPECIFIC BINDING CONJUGATE, RELATED PHARMACEUTICAL COMPOSITIONS AND USE

ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER

CELL PENETRATING CONJUGATES AND METHODS OF USE THEREOF

Antigen binding proteins that bind PD-L1

VACCINES AGAINST ANTIGENS INVOLVED IN THERAPY RESISTANCE AND METHODS OF USING SAME

BISPECIFIC ANTIBODIES AGAINST HER2

Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis

CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN AND ENCODING POLYNUCLEOTIDES

Anti-DR5 antibodies and methods of use thereof

CD131 binding proteins and uses thereof

CLL1-TARGETING ANTIBODY AND APPLICATION THEREOF

BISPECIFIC HER2 AND CD3 BINDING MOLECULES

THERAPEUTIC CD47 ANTIBODIES

ANTIBODIES AND CONJUGATES THEREOF

EpCAM antibody and CAR-T cells

Anti-CD117 antibodies and conjugates

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND METHODS OF USE

Antagonistic anti-tumor necrosis factor receptor superfamily antibodies

Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

BI-SPECIFIC BINDING MOLECULES

Detection and Treatment of Malignant Tumours in the CNS

Bispecific antibodies that bind to CD38 and CD3

Antibody binding to human HER2 and preparation method and use thereof

Anti-mesothelin antigen-binding molecules and uses thereof

Antibody constructs for DLL3 and CD3

Cysteine engineered fibronectin type III domain binding molecules

COMBINATION OF LILRB1/2 PATHWAY INHIBITORS AND PD-1 PATHWAY INHIBITORS

BI-SPECIFIC FUSION PROTEINS FOR DEPLETION OF REGULATORY T CELLS

BISPECIFIC ANTIGEN BINDING PROTEINS AND USES THEREOF

CD3-targeting and DLL3-targeting multispecific antigen-binding molecules and uses thereof

METHOD FOR THE PRODUCTION OF BI-FUNCTIONAL CELLS TO TREAT NEOPLASIA

Conjugates comprising cell-binding agents and cytotoxic agents

Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties

Methods and compositions for treating autoimmune and inflammatory conditions

BISPECIFIC ANTIGEN BINDING MOLECULES WITH TRIVALENT BINDING TO CD40

BINDING MOIETY FOR CONDITIONAL ACTIVATION OF IMMUNOGLOBULIN MOLECULES

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

Inhibition of SCUBE2, a novel VEGFR2 co-receptor, suppresses tumor angiogenesis

TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

ANTIBODY CONSTRUCTS FOR CD70 AND CD3

ANTI-CD74 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD74 ANTIBODIES AND METHODS OF USING ANTI-CD74 ANTIBODIES

METHODS AND MATERIALS FOR MODULATING AN IMMUNE RESPONSE

MATERIALS AND METHODS FOR MODULATING DELTA CHAIN MEDIATED IMMUNITY

Human antibodies, pharmaceutical compositions and methods

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Anti-PSMA antibodies and use thereof

CD38 modulating antibody agents

Epitope specific antibodies that bind cell surface GRP78 and their use for cancer detection

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Therapeutic bacterial composition

Anti-BAFFR antibody formulations and methods of use thereof